Communities engaged in dengue vector control in Uruguay
Uruguay does not have dengue, but its proximity to neighboring countries where the disease is prevalent puts it at risk. However, a community approach to reducing breeding among the dengue-carrying mosquitoes is starting to pay off.
A career investigating malaria parasite drug resistance
For some kids, it’s outer space, for others dinosaurs. But for a Sudanese boy by the name of Gehad el-Ghazali, it was the human body — how it works and why, the cells and circuits, the muscles and blood — that sparked an early interest in science.
“Full steam ahead” was the theme at this year’s annual meeting of TDR’s 13-member Scientific and Technical Advisory Committee (STAC), where members endorsed the updates on work for 2014/15 as well as the plans for 2016/17. The meeting was overseen by a new Chair, Professor Charles Mgone, who is the Executive Director of EDCTP, the European & Developing Countries Clinical Trials Partnership.
A new call for proposals to increase research capacity is now available from EDCTP, TDR and MRC-UK. The call is intended to support projects that will develop and strengthen research capacity in sub-Saharan Africa to conduct high quality health research during infectious disease emergencies such as the Ebola virus disease (EVD) outbreak in West Africa.
The Global Health Investment Fund (GHIF) has committed US$ 10 million to support completing the dossier for the registration of moxidectin for the treatment of onchocerciasis. Medicines Development for Global Health (MDGH), an Australian not-for-profit biopharmaceutical company, will be managing the work.
A new research uptake network was launched at the end of a recent conference and training event held in Nairobi. The event brought together communication professionals, researchers, policy-makers, practitioners and journalists to explore emerging issues and the concept of research uptake, and the network is now opening to anyone interested.